As part of this trial and subsequent p3 will that confer the IP rights to Clarity on cu67 as a single agent and a combo therapy if approved?
Ann: First patient treated in the Phase II of the SECuRE trial, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.18 |
Change
-0.060(2.68%) |
Mkt cap ! $703.7M | |||
| Open | High | Low | Value | Volume |
| $2.24 | $2.28 | $2.18 | $3.132M | 1.414M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 139 | $2.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.19 | 67044 | 71 |
View Market Depth
| Last trade - 15.32pm 18/06/2025 (20 minute delay) ? |
| CU6 (ASX) Chart |